Cormorant Asset Management, LP Q3 2023 significant ownership

Add to watchlist

Cormorant Asset Management, LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Cormorant Asset Management, LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Ambrx Biopharma Inc.March 13, 202342,771,365-
Altimmune, Inc.February 14, 20232,600,000-
Arcellx, Inc.February 14, 20232,075,000-
BioAtla, Inc.February 14, 20232,499,250-
Eledon Pharmaceuticals, Inc.February 14, 20231,391,663-
GreenLight Biosciences Holdings, PBCFebruary 14, 20234,751,020-
Prometheus Biosciences, Inc.February 14, 2023700,000-
Tango Therapeutics, Inc.February 14, 20231,000,000-
VectivBio Holding AGFebruary 14, 20231,515,087-
Viridian Therapeutics, Inc.\DEFebruary 14, 20231,100,000-
Avidity Biosciences, Inc.December 27, 20221,000,000-
Atea Pharmaceuticals, Inc.February 14, 2022300,000-
C4 Therapeutics, Inc.Sold outFebruary 14, 20220-
Forma Therapeutics Holdings, Inc.February 14, 20223,171,644-
Galecto, Inc.Sold outFebruary 14, 20220-
OMEROS CORPSold outFebruary 14, 20220-
Revolution Medicines, Inc.February 14, 2022886,786-
Turning Point Therapeutics, Inc.February 14, 20221,540,780-
AGENUS INCFebruary 16, 20216,737,865-
Arcturus Therapeutics Holdings Inc.Sold outFebruary 16, 20210-
AVEO PHARMACEUTICALS, INC.Sold outFebruary 16, 20210-
ChemoCentryx, Inc.February 16, 20211,154,566-
CONSTELLATION PHARMACEUTICALS INCSold outFebruary 16, 20210-
Principia Biopharma Inc.Sold outFebruary 16, 20210-
Stoke Therapeutics, Inc.February 16, 2021434,469-
Viridian Therapeutics, Inc.\DEJanuary 19, 2021459,144-
Eledon Pharmaceuticals, Inc.January 04, 20211,415,500-
Apellis Pharmaceuticals, Inc.February 14, 20201,247,685-
AVROBIO, Inc.February 14, 202097,298-
Dicerna Pharmaceuticals IncSold outFebruary 14, 20200-
Immunovant, Inc.February 14, 2020215,892-
InflaRx N.V.Sold outFebruary 14, 20200-
Kezar Life Sciences, Inc.Sold outFebruary 14, 20200-
Mirati Therapeutics, Inc.February 14, 20201,669,096-
NextCure, Inc.February 14, 2020936,958-
Quotient LtdFebruary 14, 20203,283,747-
X4 Pharmaceuticals, IncFebruary 14, 2020331,578-
Health Sciences Acquisitions CorpMay 20, 2019215,892-
EIGER BIOPHARMACEUTICALS INCMay 03, 20191,195,480-
ANAPTYSBIO INCFebruary 14, 20191,025,273-
CONTRAFECT CorpFebruary 14, 20195,272,342-
Gemphire Therapeutics Inc.February 14, 201932,938-
Intec Pharma Ltd.Sold outFebruary 14, 20190-
PROTEOSTASIS THERAPEUTICS, INC.Sold outFebruary 14, 20190-
Trillium Therapeutics Inc.Sold outFebruary 14, 20190-
Axonics Modulation Technologies, Inc.November 09, 2018346,213-
Aptose Biosciences Inc.Sold outFebruary 14, 20180-
Corbus Pharmaceuticals Holdings, Inc.Sold outFebruary 14, 20180-
Ignyta, Inc.Sold outFebruary 14, 20180-
Minerva Neurosciences, Inc.February 14, 2018512,159-
TiGenix NVFebruary 14, 20188,300,017-
Zynerba Pharmaceuticals, Inc.Sold outFebruary 14, 20180-
ARDELYX, INC.February 14, 20171,841,573-
Cellectar Biosciences, Inc.February 14, 201789,304-
GENVEC INCSold outFebruary 14, 20170-
MyoKardia IncFebruary 14, 20171,205,383-
Recro Pharma, Inc.February 14, 2017501,878-
Sorrento Therapeutics, Inc.February 14, 20171,588,861-
SUNESIS PHARMACEUTICALS INCFebruary 14, 2017831,500-
Vitae Pharmaceuticals, IncSold outFebruary 14, 20170-
LORUS THERAPEUTICS INCApril 14, 201413,000,000-

Compare quarters

Export Cormorant Asset Management, LP's holdings

CSVXLS